SAN FRANCISCO, Aug. 14, 2025 /PRNewswire/ -- Citizen Health, a patient-powered platform transforming rare disease care, announced today it has…
Built to Connect Patients and Providers, the HFSA Database is Now Open for Searching and Submissions WASHINGTON, Aug. 14, 2025…
Cancer Risk Survey shows that more than half of women at high-risk for hereditary cancer would feel "empowered" by more…
Cancer Risk Survey shows that more than half of women at high-risk for hereditary cancer would feel "empowered" by more…
Collaboration brings whole-exome based hereditary cancer insights to urologists and their patients by offering it alongside Veracyte's Decipher Prostate Test…
VYJUVEK approved for the treatment of DEB from birth with flexible administration options including home dosing and the option for…
- By examining over 100 unique variants associated with the CASR gene causative of ADH1, the average frequency of gain-of-function…
WEST PALM BEACH, FLORIDA, July 18, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), today…
TWINSBURG, Ohio, July 14, 2025 /PRNewswire/ -- Xact Laboratories, a Biotech innovator in evidence-based medication guidance, has received a landmark United…
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- Several experts are seeing…